Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manjie Xing

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Gut|July 11, 2022
Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilitiesShamaine Wei Ting Ho, Taotao Sheng, Manjie Xing, et al.
Cancer Research|May 18, 2022
Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric CancerAmrita M Nargund, Chang Xu, Amit Mandoli, et al.
Cancer Cell|January 2, 2018
Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric CancerKie Kyon Huang, Kalpana Ramnarayanan, Feng Zhu, et al.
Nature Communications|September 29, 2016
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneityWen Fong Ooi, Manjie Xing, Chang Xu, et al.
Cancer Discovery|March 22, 2017
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaAditi Qamra, Manjie Xing, Nisha Padmanabhan, et al.
Gut|August 26, 2021
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibitionRaghav Sundar, Kie-Kyon Huang, Vikrant Kumar, et al.
Cancer Discovery|September 13, 2017
<i>VHL</i> Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell CarcinomaXiaosai Yao, Jing Tan, Kevin Junliang Lim, et al.
The Journal of Clinical Investigation|May 5, 2020
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Wen Fong Ooi, Jing Tan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Gut|July 11, 2022
Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilitiesShamaine Wei Ting Ho, Taotao Sheng, Manjie Xing, et al.
Cancer Research|May 18, 2022
Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric CancerAmrita M Nargund, Chang Xu, Amit Mandoli, et al.
Cancer Cell|January 2, 2018
Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric CancerKie Kyon Huang, Kalpana Ramnarayanan, Feng Zhu, et al.
Nature Communications|September 29, 2016
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneityWen Fong Ooi, Manjie Xing, Chang Xu, et al.
Cancer Discovery|March 22, 2017
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaAditi Qamra, Manjie Xing, Nisha Padmanabhan, et al.
Gut|August 26, 2021
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibitionRaghav Sundar, Kie-Kyon Huang, Vikrant Kumar, et al.
Cancer Discovery|September 13, 2017
<i>VHL</i> Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell CarcinomaXiaosai Yao, Jing Tan, Kevin Junliang Lim, et al.
The Journal of Clinical Investigation|May 5, 2020
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancerManjie Xing, Wen Fong Ooi, Jing Tan, et al.
Pageof 2